Die Influenza ist bei einer Infektionsrate von 10-20 % der Bevölkerung und einer Todesrate in Deutschland von bis zu 10000 Menschen pro Jahr eine ernst zu nehmende Erkrankung.
Insbesondere chronisch Kranke und ältere Personen sind durch sekundäre bakterielle Pneumonien gefährdet. Die jährliche Schutzimpfung von Risikogruppen ist die wichtigste präventive Maßnahme. Wichtig erscheint, dass Ärzte und Pflegepersonal das Influenza-Virus während der Inkubationszeit oder bei inapparenten Verläufen auf ungeimpfte Personen übertragen können. Um das medizinische Personal und deren Patienten zu schützen wird für diese Berufsgruppe eine Impfung empfohlen.
Summary
With an infection rate of up to 20 % of the general population and an annual mortality rate in Germany of up to 10000 persons, influenza is an illness that must be taken seriously. In particular the chronically ill and elderly patients are at risk from secondary bacterial pneumonia. The annual vaccination of risk groups is the most effective measure currently available. An important consideration would appear to be that physicians and care-providing personnel should not be capable of transmitting the influenza virus during the incubation period or during the course of a symptom-free illness to unprotected persons. In order to protect both the medical personnel and their patients, vaccination of this professional group is recommended.
3
Treanor JJ.
Influenza virus.
In: Mandell GL, Bennett JE, Dolin R (Eds). Principles and Practice of Infectious Diseases.
Philadelphia: Chuchill Livingstone.
2000;
1823
4
Greaves K, Oxford JS, Price CP. et al. .
The prevalence of myocarditis and skeletal muscle injury during acute viral infection in adults: measurement of cardiac troponins I and T in 152 patients with acute influenza infection.
Arch Intern Med.
2003;
163
165-168
5
Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J.
Clinical signs and symptoms predicting influenza infection.
Arch Intern Med.
2000;
160
3243-3247
7
Cooper NJ, Sutton AJ, Abrams KR. et al. .
Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials.
BMJ.
2003;
326
1235-1242
8
Wilde JA, McMillan JA, Serwint J. et al. .
Effectiveness of influenza vaccine in health care professionals: a randomized trial.
JAMA.
1999;
281
908-913
11
Elder AG, O'Donnell B, McCruden EA. et al. .
Incidence and recall of influenza in a cohort of Glasgow healthcare workers during the 1993-4 epidemic: results of serum testing and questionnaire.
BMJ.
1996;
313
1241-1242
12
Potter J, Stott DJ, Roberts MA. et al. .
Influenza vacination of health care workers in long-term-care hospitals reduces the mortality of elderly patients.
J Infect Dis.
1997;
175
1-6
